Skip to main content
SpringerLink
Log in
Book cover

National Institute of Allergy and Infectious Diseases, NIH pp 271–277Cite as

Virus Receptor Wars: Entry Molecules Used for and Against Viruses Associated with AIDS

  • Conference paper

  • 855 Accesses

Part of the book series: Infectious Disease ((ID))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Earp LJ, Delos SE, Park HE, White JM (2004) The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 285:25–66.

    Article  Google Scholar 

  2. Gallo RC, Montagnier L (2003) Retrospective: the discovery of HIV as the cause of AIDS. N Engl J Med 349:2283–2285.

    Article  PubMed  CAS  Google Scholar 

  3. Ganem D (2006) KSHV infection and the pathogenesis of Kaposi's sarcoma. Ann Rev Path 1:273–296.

    Article  CAS  Google Scholar 

  4. Dey B, Berger EA (2003) Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptors. In Current Protocols in Immunology (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds.), pp. 12.10.1–12.10.20. John Wiley & Sons, Inc., New York.

    Google Scholar 

  5. Wyatt R, Sodroski J (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884–1888.

    Article  PubMed  CAS  Google Scholar 

  6. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmem-brane, G protein-coupled receptor. Science 272:872–877.

    Article  PubMed  CAS  Google Scholar 

  7. Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657–700.

    Article  PubMed  CAS  Google Scholar 

  8. Lusso P (2006) HIV and the Chemokine system: 10 years later. EMBO J 25:447–456.

    Article  PubMed  CAS  Google Scholar 

  9. Husman AMD, Schuitemaker H (1998) Chemokine receptors and the clinical course of HIV-1 infection. Trends Microbiol 6:244–249.

    Article  Google Scholar 

  10. Pierson TC, Doms RW, Pohlmann S (2004) Prospects of HIV-1 entry inhibitors as novel therapeutics. Rev Med Virol 14:255–270.

    Article  PubMed  CAS  Google Scholar 

  11. Margolis L, Shattock R (2006) Selective transmission of CCR5-utilizing HIV-1: the “gatekeeper” problem resolved? Nat Rev Microbiol 4:312–317.

    Article  PubMed  CAS  Google Scholar 

  12. O'Brien SJ, Moore JP (2000) The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 177:99–111.

    Article  PubMed  Google Scholar 

  13. Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705–711.

    Article  PubMed  CAS  Google Scholar 

  14. Burton DR, Stanfield RL, Wilson IA (2005) Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci USA 102:14,943–14,948.

    Article  CAS  Google Scholar 

  15. Wei XP, Decker JM, Wang SY, Hui HX, Kappes JC, Wu XY, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM (2003) Antibody neutralization and escape by HIV-1. Nature 422:307–312.

    Article  PubMed  CAS  Google Scholar 

  16. Hartley O, Klasse PJ, Sattentau QJ, Moore JP (2005) V3: HIV's switch-hitter. AIDS Res Hum Retrovir 21:171–189.

    Article  PubMed  CAS  Google Scholar 

  17. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PWLH, Robinson J, Van Ryk D, Wang LP, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420:678–682.

    Article  PubMed  CAS  Google Scholar 

  18. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648–659.

    Article  PubMed  CAS  Google Scholar 

  19. Chen B, Vogan EM, Gong HY, Skehel JJ, Wiley DC, Harrison SC (2005) Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834–841.

    Article  PubMed  CAS  Google Scholar 

  20. Decker JM, Bibollet-Ruche F, Wei XP, Wang SY, Levy DN, W a n g WQ, Delaporte E, Peeters M, Derdeyn CA, Allen S, Hunter E, Saag MS, Hoxie JA, Hahn BH, Kwong PD, Robinson JE, S h a w GM (2005) Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 201:1407–1419.

    Article  PubMed  CAS  Google Scholar 

  21. Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, Kwong PD, Wyatt RT, Sodroski J, Burton DR (2003) Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol 77:10,557–10,565.

    Article  CAS  Google Scholar 

  22. Stiegler G, Katinger H (2003) Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection. J Antimicrob Chemother 51:757–759.

    Article  PubMed  CAS  Google Scholar 

  23. Dey B, Del Castillo CS, Berger EA (2003) Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor. J Virol 77:2859–2865.

    Article  PubMed  CAS  Google Scholar 

  24. Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77: 10,179–10,185.

    Article  CAS  Google Scholar 

  25. Pertel PE (2002) Human herpesvirus 8 glycoprotein b (gB), gH, and gL can mediate cell fusion. J Virol 76:4390–4400.

    Article  PubMed  CAS  Google Scholar 

  26. Kaleeba JAR, Berger EA (2006) Broad target cell selectivity of Kaposi's sarcoma-associated herpesvirus glycoprotein-mediated cell fusion and virion entry. Virology 354:7–14.

    Article  PubMed  CAS  Google Scholar 

  27. Akula SM, Pramod NP, Wang FZ, Chandran B (2002) Integrin alpha 3 beta 1 (cd 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108:407–419.

    Article  PubMed  CAS  Google Scholar 

  28. Kaleeba JAR, Berger EA (2006) Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311:1921–1924.

    Article  PubMed  CAS  Google Scholar 

  29. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y (2004) CATs and HATs: the SLC7 family of amino acid transporters. Pflug Arch Eur J Phy 447:532–542.

    Article  CAS  Google Scholar 

  30. Wang JF, Zhang XF, Chandran B, Groopman JE (2004) Human herpesvirus-8 (HHV-8/KSHV) induces reactive oxygen species in endothelial cells that facilitate virus infection. Blood 104:174A–175A.

    Google Scholar 

  31. Herzenberg LA, DeRosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94:1967–1972.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    Edward A. Berger

Authors
  1. Edward A. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Vassil St. Georgiev PhD Karl A. Western MD John J. McGowan PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this paper

Cite this paper

Berger, E.A. (2008). Virus Receptor Wars: Entry Molecules Used for and Against Viruses Associated with AIDS. In: Georgiev, V.S., Western, K.A., McGowan, J.J. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-569-5_31

Download citation

Publish with us

Policies and ethics

Search

Navigation